Researchers have identified a compound that could block certain life-threatening and hard-to-treat allergic reactions.

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...

Additionally, their pipeline includes other promising candidates (BLU-808 and Elenestinib) for mast cell disorders and genetically driven cancers. Their recent data seems to reinforce Ayvakit’s ...

AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...

According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal allergy, eczema or food allergy.

Dr Rehana Kausar Spring in Kashmir is perhaps the most beautiful season with daffodils, irises and tulips competing to bloom.

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...